Â鶹ŮÓÅ

The gene that makes some people more vulnerable to Alzheimer’s disease as adults also affects the brain development and mental abilities of children, a new study shows. Researchers who examined brain scans of 1,187 kids and teens found distinct patterns in the size and structure of the cortex, hippocampus and other important structures. These patterns were linked with different versions of a gene known as APOE, which may play a role in up to 25% of Alzheimer’s cases. (Kaplan, 7/13)

Five drug makers, including Cambridge-based Biogen Inc., are banding together with academic scientists to form a research consortium aimed at speeding development of therapies for Alzheimer’s, a neurological disorder that has stubbornly eluded treatments. The new group, which will be formally launched Thursday night at an event at Massachusetts General Hospital, is called the Massachusetts Center for Alzheimer Therapeutic Science, or MassCATS. It will be based at a Mass. General research center. (Weisman, 7/14)